Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)
China
· Delayed Price · Currency is CNY 7.77
+0.05 (0.65%)
Apr 24, 2025, 2:45 PM CST
SHE:300434 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Net Income | 45.55 | 126.2 | 218.79 | 66.48 | -687.66 | 120.33 | Upgrade
|
| Depreciation & Amortization | 93.47 | 93.47 | 91.32 | 87.12 | 86.07 | 81.69 | Upgrade
|
| Other Amortization | 3.07 | 3.07 | 3.36 | 1.59 | 2.31 | 4.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.25 | -0.25 | -17.77 | 0 | 0.04 | -0.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | 68.3 | 68.3 | 1.4 | 25.89 | 668.8 | 21.7 | Upgrade
|
| Loss (Gain) From Sale of Investments | 18.43 | 18.43 | 11.97 | 9.67 | 1.57 | -0.26 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.88 | -0.88 | 2.08 | 4.26 | 5.04 | 2.49 | Upgrade
|
| Other Operating Activities | 62 | -10.14 | 0.82 | 4.28 | 4.7 | 7.32 | Upgrade
|
| Change in Accounts Receivable | 88.62 | 88.62 | -109.55 | -220.68 | 190.15 | 17.99 | Upgrade
|
| Change in Inventory | -41.05 | -41.05 | 20.09 | -30.38 | -43.63 | 10.01 | Upgrade
|
| Change in Accounts Payable | -183.04 | -183.04 | 106.14 | 198.3 | -93.02 | -71.3 | Upgrade
|
| Operating Cash Flow | 142.63 | 151.14 | 323.04 | 136.4 | 132.99 | 186.47 | Upgrade
|
| Operating Cash Flow Growth | -49.17% | -53.21% | 136.84% | 2.56% | -28.68% | -6.34% | Upgrade
|
| Capital Expenditures | -74.3 | -66.1 | -54.15 | -85.36 | -35.08 | -27.2 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.08 | 3.16 | 0.71 | 0.15 | 0.03 | 0.24 | Upgrade
|
| Cash Acquisitions | - | - | - | -201.01 | - | -86.55 | Upgrade
|
| Investment in Securities | -275.46 | -78.51 | -9.97 | 19.94 | 3.82 | -26.11 | Upgrade
|
| Other Investing Activities | 2.04 | 0.95 | 2.25 | 0.68 | 2.35 | 0.83 | Upgrade
|
| Investing Cash Flow | -345.65 | -140.5 | -61.16 | -265.61 | -28.88 | -138.8 | Upgrade
|
| Short-Term Debt Issued | - | 117.61 | 15 | - | 10 | - | Upgrade
|
| Total Debt Issued | 142.61 | 117.61 | 15 | - | 10 | - | Upgrade
|
| Short-Term Debt Repaid | - | -17 | -5 | -46 | -8 | -17 | Upgrade
|
| Long-Term Debt Repaid | - | -0.65 | -0.04 | -0.28 | - | - | Upgrade
|
| Total Debt Repaid | -47.65 | -17.65 | -5.04 | -46.28 | -8 | -17 | Upgrade
|
| Net Debt Issued (Repaid) | 94.96 | 99.96 | 9.96 | -46.28 | 2 | -17 | Upgrade
|
| Issuance of Common Stock | 1.1 | - | - | - | - | 1.46 | Upgrade
|
| Common Dividends Paid | -45.06 | -0.74 | -0.11 | -0.33 | -30.58 | -36.74 | Upgrade
|
| Other Financing Activities | -1.93 | -0.64 | -71.7 | - | - | - | Upgrade
|
| Financing Cash Flow | 49.07 | 98.57 | -61.86 | -46.61 | -28.58 | -52.27 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.62 | 0.46 | 1.48 | -0.21 | -0.42 | -0.06 | Upgrade
|
| Net Cash Flow | -154.57 | 109.68 | 201.5 | -176.04 | 75.12 | -4.67 | Upgrade
|
| Free Cash Flow | 68.33 | 85.04 | 268.89 | 51.03 | 97.91 | 159.27 | Upgrade
|
| Free Cash Flow Growth | -70.48% | -68.37% | 426.92% | -47.88% | -38.52% | -7.58% | Upgrade
|
| Free Cash Flow Margin | 6.00% | 7.03% | 21.64% | 4.84% | 12.60% | 15.84% | Upgrade
|
| Free Cash Flow Per Share | 0.16 | 0.21 | 0.66 | 0.13 | 0.24 | 0.40 | Upgrade
|
| Cash Income Tax Paid | 174.11 | 262.23 | 100.93 | 111.54 | 112.45 | 149.24 | Upgrade
|
| Levered Free Cash Flow | -94.35 | 77.09 | 263.72 | 27.39 | 104.95 | 122.76 | Upgrade
|
| Unlevered Free Cash Flow | -94.35 | 77.51 | 264 | 27.4 | 105.05 | 123.35 | Upgrade
|
| Change in Net Working Capital | 206.88 | 103.32 | -47.97 | 48.11 | -56.52 | 38.01 | Upgrade
|
Updated Oct 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.